is the CEO of Nualtis, where he drives the company’s strategic direction and growth. He brings leadership experience from Bayer Pharmaceuticals, atai Life Sciences, and McKinsey & Company. With academic training in biotechnology, business, and innovation management, he is focused on advancing oral film drug delivery and building a high-performing team to improve therapeutic outcomes for humans and animals.

is Chief Scientific Officer at Nualtis, overseeing oral film formulation and product development. With over 20 years in pharmaceutical R&D and degrees in Chemistry from the University of Sherbrooke, she leads the scientific advancement of Nualtis’ pipeline. Nadine specializes in transforming complex therapeutic needs into high-performance oral film drug delivery systems.

is VP of Finance at Nualtis, where she leads financial planning, controls, and strategic growth support. A CPA with 20+ years in pharma and biotech, she holds degrees in Accountancy from Concordia University. Karen brings strong financial leadership to support operational excellence and long-term expansion across human and veterinary health portfolios.

is VP of Quality Operations at Nualtis, with 20+ years of experience in QC, QA, and regulatory compliance. She holds a Ph.D. in Chemistry and has led successful FDA and Health Canada inspections. Nina focuses on building robust quality systems that support innovation and ensure compliance across human and animal health programs.

is Business Development Lead and General Counsel at Nualtis. With legal and scientific training, he guides IP strategy, partnerships, and commercial development. Tommy holds law degrees and a Master’s in Chemistry, and brings over a decade of experience in pharma law. He aligns legal, business, and innovation strategy to drive company growth.